Deutsche Bank
VOR icon

Deutsche Bank’s Vor Biopharma VOR Stock Holding History

Deutsche Bank’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$743K Buy
+40,351
New +$611K ﹤0.01% 2548
2024
Q2 		– Sell
-1,592
Closed -$75.4K – 3706
2024
Q1 		$75.4K Hold
1,592
– – ﹤0.01% 3272
2023
Q4 		$71.6K Buy
+1,592
New +$65.7K ﹤0.01% 3352
2022
Q2 		– Sell
-531
Closed -$64K – 4339
2022
Q1 		$64K Sell
531
-61
-10% -$10.4K ﹤0.01% 3757
2021
Q4 		$138K Buy
592
+30
+5% +$8.65K ﹤0.01% 3557
2021
Q3 		$176K Buy
562
+198
+54% +$58.9K ﹤0.01% 3632
2021
Q2 		$136K Sell
364
-11
-3% -$5.43K ﹤0.01% 4001
2021
Q1 		$324K Buy
+375
New +$317K ﹤0.01% 3371

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Deutsche Bank's VOR Position: Q2 2026 in Review

Deutsche Bank opened a new position in Vor Biopharma (VOR) in Q2 2026: 40,351 shares worth $743K. The stake represents ﹤0.01% of the portfolio and ranks #2548 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in VOR as recently as Q1 2024.

Deutsche Bank first reported a position in VOR in Q1 2021 and has held it in 8 quarters since. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Deutsche Bank held 40,351 shares of Vor Biopharma worth $743K as of Q2 2026.
  • Vor Biopharma was a new Deutsche Bank position in Q2 2026.
  • Vor Biopharma made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2548 holding.
  • Deutsche Bank first reported a position in Vor Biopharma in Q1 2021 and has held it in 8 quarters since.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.